India, July 27 -- Today's top biotech gainers include Entera Bio, following an oversubscribed private placement financing; Gossamer, which is progressing toward a planned Seralutinib NDA submission in... Read More
India, July 27 -- Katahdin Bankshares Corp. (KTHN.OB) released earnings for second quarter that Dropped, from last year The company's bottom line totaled $2.41 million, or $0.76 per share. This compa... Read More
India, July 27 -- Virtuix Holdings Inc. (VTIX), said on Monday that Tesla, Inc. (TSLA) purchased an Omni One Enterprise system for its Optimus humanoid robot program. On the Nasdaq, shares of Virtuix... Read More
India, July 27 -- Humacyte, Inc. (HUMA), a biotechnology company developing bioengineered human tissues, announced on Monday that the U.S. Food and Drug Administration (FDA) has accepted its Investiga... Read More
India, July 27 -- InnoCare Pharma (INCPF) announced that its novel TYK2 inhibitor, Fadeucravacitinib, achieved the primary endpoint in a registrational Phase III trial in patients with moderate-to-sev... Read More
India, July 27 -- Shares of Edible Garden AG Incorporated (EDBL) are climbing about 20 percent on Monday morning after it received a fresh cut herb distribution order from Walmart across the Mid-Atlan... Read More
India, July 27 -- Baker Hughes Company (BKR) shares climbed $4.70, or 8.21 percent, to $61.95 after the energy technology company reported late Sunday a sharp increase in second-quarter orders and exp... Read More
India, July 27 -- Shares of Forte Biosciences, Inc. (FBRX) jumped 40% on Monday morning after argenx (ARGX) agreed to acquire the clinical-stage biotechnology company in an all-cash deal valued at app... Read More
India, July 27 -- Ranger Energy Services, Inc. (RNGR) reported earnings for second quarter that Dropped, from the same period last year The company's earnings totaled $6.9 million, or $0.29 per share... Read More
India, July 27 -- AstraZeneca's (AZN) rare disease unit, Alexion, has announced results from its Phase III program evaluating Ultomiris (ravulizumab) in patients with thrombotic microangiopathy after ... Read More